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Abstract X-ray crystal structure analysis of mercuric reductase suggested that the binding site for Hg2’ consisted of two tyrosine residues, Tyti@ 
and Tyr605, as well as two cysteine residues, Cys”” and Cys6*‘. We have previously shown that mutagenesis of TyrM5 to Phe lowered the k-t of the 
enzyme 6-fold, whereas the same mutation of TyI364 resulted in a reduction of 160-fold [(1993) Biochemistry 32,7475-74781. Tyr”o’ occupies the same 
position in mercuric reductase as the active site His residue in the related enzyme glutathione reductase. The mutation of Tyr605 ofmercuric reductase 
to a His residue produced a24-fold decrease in k,, and a 15-fold ecrease in K&. The in vivo resistance to Hg2’ of E. coli strains carrying wild type 
or mutant merA genes correlated with the in vitro measurements of k-,/X;, for mercuric reductase activity. 
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1. Introduction 
Mercuric reductase (MerA), one of the proteins encoded by 
the mercury resistance (mer) operon, reduces He to mercury 
metal Hg” using NADPH as a source of reducing power [l]. It 
is a member of the family of flavin-dependent disulfide oxidore- 
ductases, which includes glutathione reductase. All of these 
enzymes are active as homodimers and catalyse the transfer of 
electrons from NADPH via an enzyme-bound FAD into a 
disulfide bond at the active site. 
The X-ray crystal structure of the enzyme from BuciZlus sp. 
strain RC607 suggested that the probable binding site for Hg*+ 
was formed by two cysteine residues, Cyszo7 and Cyszo8’ (i.e. 
C~S~‘~ from the other subunit) and two tyrosine residues, Ty? 
and Tyr605’ [2]. Cyszo7 is one of the active site cysteine residues 
present in other members of this family, whereas CYSTS* forms 
part of a C-terminal extension unique to MerA. Although 
Ty?’ is also conserved in other members of this family, Tyra5 
is located at the homologous position in MerA as the active site 
His residue in glutathione reductase [2], Site-directed mut- 
agenesis hows that the roles of the two tyrosine residues are 
not equivalent and that the substitution of Phe for Tyr605 had 
a much less drastic effect on enzyme activity in vitro than a 
similar substitution of Ty?” [3]. We postulated that the change 
from the strongly coordinating imidazole side chain of His to 
the more weakly coordinating side chain of Tyr, which could 
occur by only a single base change from CA(CiT) for His to 
TA(C/T) for Tyr at this position, could have been an important 
change in enabling MerA to bind Hg2+ loosely enough to be 
able to reduce it. To investigate this possibility, we constructed 
a mutant of MerA, in which Tyrm5 is changed to His, and 
characterized the effect of this mutation on enzyme activity in 
vitro. In addition, we have examined the effect of this and 
3 other mutations (Y264F, Y605F and Y264,605F) on in vivo 
resistance to mercuric chloride. 
*Corresponding author. Fax: (44) (703) 593781. 
2. Materials aud methods 
2.1. Mutagenesis of merA 
Site-directed mutagenesis of the merA gene was performed as previ- 
ously described [3]. A single base change in codon 605 from Tyr (TAT) 
to His (CAT) was introduced using the oligonucleotide 5’ GAT TCC 
ACA TCT AAC AAT 3’. The presence of the mutation was confirmed 
by sequence analysis. A 540 bp CZaUHindIII fragment containing the 
mutation was ligated into the wild type merA gene in expression vector 
pKK223-3 (Pharmacia, Piscataway, NJ), which had been previously cut 
with the same enzymes. The final construct was checked by restriction 
analysis and the merA gene was sequenced. 
2.2. Overexpression, purification and characterization of MerA 
MerA protein was expressed in the E. coli strain XLlBlue (Strat- 
agene, La Jolla, CA). Cultures were grown in 2 x TY media, supple- 
mented with 100 pg/ml ampicillin at 37’C until an OD, of 2 was 
reached. Expression was induced by the addition of IPTG to a final 
concentration of 0.2 mM and the cells were grown a further 3.5 h before 
harvesting. MerA was purified as previously described [4], except that 
the buffer used was 50 mM potassium phosphate, pH 7.5, containing 
0.5 mM EDTA and 1% (v/v) 2-mercaptoethanol (Buffer A) and the 
desalted protein was loaded onto a column of DEAE-Sepharose, 
washed extensively with Buffer A and eluted with a gradient of O-O.3 
M NaCl in buffer A. The purified protein was characterized by SDS- 
polyacrylamide gel electrophoresis and kinetic analysis as previously 
described [3]. 
2.3. Assay of in vivo resistance to HgCI, 
A functional He transport system was constructed by ligating a 1.2 
kb BamHIIHindIII fragment of the plasmid pUB3466.BS2 <a generous 
gift of Prof. N. Brown. Universitv of Birmineham) into rrACYC184 
which had been cut with the same enzymes. ?his fragment contains 
merR, merT and merP genes from transposon TnSOl which together 
constitute a Hg2’-inducible He transport system [l]. The resulting 
plasmid pDR1 was introduced into the E. coli strain XA90, together 
with the expression plasmid pKK223-3 containing wild type or mutant 
merA genes, and cells containing both plasmids were selected with 
ampicillin and chloramphenicol. Sensitivities in vivo to mercuric chlo- 
ride were measured by minimum inhibitory concentration (MIC) and 
efficiency of plating (EOP) assays as described previously [5], except 
that the LB plates used contained 100 pg/ml ampicillin, 25 @ml chlo- 
ramphenicol, 0.2 mM IPTG and varying concentrations of HgCl,. The 
MIC was defined as the lowest concentration of Hg2’ tested that se- 
verely affected colony growth and the EOP was the ratio of number of 
viable cells at the Hg2’ concentration tested to the number of viable cells 
in the absence of He. 
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Table 1 
Kinetic constants for reduction of H$ and transhydrogenation of Thio-NADP’ by wild type and Y605H MerA enzymes” 
Enzyme 
Z#gz+) 
$1) k&G,, L, (s-l) 
Wild typeb 
Y605H 
Y605Fb 
Y264Fb 
Y264,605Fb 
30 
3;.g 
6 
6 
12 
0.50 
1.9 
0.073 
0.011 
(M-’ .s-‘) 
4.0 x 105 
2.6 x IO5 
4.9 x 104 
1.2 x 104 
1.8 x 10’ 
(Transhydrog.) 
1.3 
0.8 
0.9 
::: 
G, (NADPH) 
01M) 
(Transhydrog.) 
0.3 
1.8 
0.6 
2.9 
1.4 
“Values of k,, and & are apparent values, as in each case only one substrate was varied. 
bData taken from [3]. 
3. Results and discussion 
3.1. Analysis of in vitro activity of MerA Y605H 
The results of kinetic analysis of MerA Y605H are shown in 
Table 1. Analysis of Hg” reductase activity of MerA Y605H 
showed that the k,, of the enzyme had been reduced by 24-fold 
compared to wild type enzyme and the &, of the enzyme for 
Hg’+ had been lowered by about ISfold. The effect of this 
mutation at position 605 on HgZ’ reductase activity differed 
markedly from a mutant previously produced in which Tyr605 
was changed to Phe. This mutant showed only a 30% increase 
in K, for Hg2+ compared to wild type and the k-t was lowered 
only 6-fold. These results agree with the proposition that the 
replacement of the His residue which is found at the equivalent 
of position 605 in other members of this family of enzymes with 
the Tyr residue found in MerA would result in an enzyme that 
would bind HF more loosely, and increase the ability of the 
enzyme to reduce it to Hg’. It is interesting, however, that the 
Table 2 
Minimum inhibitory concentration (MIC) of mercuric chloride for 
E. cob XA90 expressing wild type or mutant MerA enzymes 
Hg*+ transport MerA enzyme 
system present expressed 
None” Noneb 
pDR1 Noneb 
pDR1 Wild type 
pDR1 Y605H 
pDR1 Y605F 
pDR1 Y264F 
pDR1 Y264,605F 
$ACYC184 vector present. 
bpKK223-3 vector present. 
MIC 
CuM HgClJ 
5&75 
16 
>300 
300 
100 
50 
18-20 
value of k,,JK, for MerA Y605H is reduced less than 2-fold 
compared to the wild type enzyme. 
Members of the flavin-dependent disulfide oxidoreductase 
family are able to catalyse the reduction of thio-NADP’ by 
NADPH. This reaction is believed to involve the reduction and 
reoxidation of the enzyme-bound flavin and is a useful control 
to check that any mutation made has not grossly affected pro- 
tein folding [6]. MerA Y605H differed only minimally from the 
wild type enzyme in transhydrogenation activity and the small 
changes observed did not correlate with changes in HP reduc- 
tase activity seen in this and other mutant MerA enzymes [3]. 
3.2. Measurements of in vivo resistance to mercuric chloride 
Hg2+ resistance in bacteria involves the transport of Hg2+ into 
the cell, followed by its reduction by MerA to Hg’, which then 
diffuses out of the cell. To investigate the in vivo effect of 
mutations affecting MerA, the proteins responsible for Hg2+ 
transport into and within the cell must be present. To allow this, 
we constructed a plasmid (pDR 1) carrying merT and merP, two 
genes encoding Hg2’ transport proteins, and merR which en- 
codes the protein responsible for their Hg*‘-dependent ran- 
scription [l]. This plasmid was constructed using pACYC184, 
which carries the chloramphenicol acetyltransferase gene and 
is compatible with the plasmid used to express wild type or 
mutant MerA proteins. 
The results of the minimum inhibitory concentration assay 
for HF resistance are shown in Table 2. The MIC for XA90 
cells carrying only the two vectors pACYC184 and pKK223-3 
was 50-75 ,uM Hg*+. The introduction of a Hg2+-transport 
system reduced the MIC to 20 ,uM Hg2+. Cells containing both 
a functional He-transport system and expressing wild type 
MerA had MIC values greater than the highest Hfl concentra- 
Table 3 
Efficiencies of plating for E. coli XA90 containing pDR1 and expressing wild type or mutant MerA enzymes 
/LM Hg’+ Enzyme expressed 
Wild type Y264F Y605F Y605H Y264,605F” 
10 1.1 1.1 1.0 0.94 0.90 
20 1.0 0.93 1.1 0.91 5.2 x lo-’ 
50 0.94 1.3 x 10-s 0.070 0.86 c2.6 x lo-’ 
75 0.82 ~2.6 x 1O-6 2.6 x 1O-4 0.58 < 2.6 x 1O-7 
100 0.93 < 2.6 x 1O-6 2.1 x 1o-4 0.082 c 2.6 x lo-’ 
200 0.95 ~2.6 x 1O-6 1.4 x 1o-4 4.1 x 1o-5 c 2.6 x lo-’ 
300 0.96 < 2.6 x lo+ 1.0 x 1o-4 1.2 x 1o-5 < 2.6 x lo-’ 
“The lowest dilution of cells expressing MerA Y264,605F tested was loo-fold, compared to l,OOO-fold for the other enzymes. Therefore, the lowest 
limit for efficiency of plating for these celis was IO-fold less than for cells expressing wild type enzyme or the other mutants tested. 
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tion tested (300 PM). The MIC of cells expressing the mutations 
tested fell between these two values and correlated with the 
value of kJ&, for HgZ’ reductase activity measured in vitro 
for each mutant. Hence, MerA Y605H which had the highest 
kJI&, of the mutants tested had a MIC of 300 PM. Similarly, 
the double mutant MerA Y264,605F which had the lowest 
kc,,/& had a MIC that on initial testing did not differ from that 
of cells carrying the He-transport system alone. When testing 
was repeated over a narrower range of Hg” concentrations, 
there was a difference in MIC for cells expressing MerA 
Y264,605F compared to those lacking MerA of 2-4 PM. The 
MIC for cells expressing the mutations MerA Y264F and 
MerA Y605F were 50 ,uM and 100 ,uM, respectively. A more 
sensitive estimation of the effect of mutations of MerA on the 
resistance of cells to mercuric chloride is the efficiency of plat- 
ing assay. The results of this assay (Table 3) confirmed those 
of the MIC assay. The in vivo resistance to Hg*+ of E. coli 
strains carrying wild type or mutant merA genes agreed well 
with the in vitro measurements of kJf& for mercuric reduc- 
tase activity and suggest hat purely kinetic measurements have 
a validity for interpreting possible in vivo implications of muta- 
tions in this enzyme. 
Although the mutation of Tyrdo5 to His in mercuric reductase 
resulted in a decrease in both K,,, and kw, for the enzyme, 
supporting the proposition that the presence of an imidazole 
side chain at position 605 could lead to tighter binding of the 
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HgZ’ substrate, the overall catalytic efficiency of the enzyme 
was decreased by less than 2-fold. This lack of effect on the 
catalytic efficiency of the mutation of Tyr605 to His in MerA 
Y605H was supported by measurements of in vivo resistance 
to mercuric chloride of cells expressing this mutant of MerA. 
This result makes it unlikely that the change from a His residue 
at position 605 to Tyr was a crucial change in the evolution of 
the ability to reduce and detoxify HgZ’ by a member of the 
flavin-dependent disulfide oxidoreductase family of enzymes. 
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